,,ii  #aahth ,,congress  #ast ,session  
,s4 #dgf  ,,in ,,the ,,senate ,,of ,,the
 ,,united ,,states  ,february #af1      
#bjbc,mr4 ,menendez 7for himself and    
,mrs4 ,blackburn7 introduced the        
following bill2 which was read twice and
 referred to the ,committee on ,finance 
,a ,,bill  ,to amend title ,,xi of the  
,social ,security ,act to protect access
 to genetically targeted technologies4  
#a4 ,short title ,this ,act may be cited
 as the ,maintaining ,investments in    
,new ,innovation ,act4  #b4 ,amendment  
to definition of qualifying single      
source drug ,section #aaib7;e7 of the   
,social ,security ,act 7#db ,u4,s4,c4   
#acbj;f-#a7;e77 is amended-- 7#a7 in    
paragraph 7#a77;,a77ii71 by inserting   
7or1 in the case of an advanced drug    
product 7as defined in paragraph 7#d771 
#aa years7 after #g years2 and  7#b7 by 
adding at the end the following new     
paragraph3  7#d7 ,advanced drug product 
defined ,for purposes of paragraph      
7#a77;,a77ii71 the term advanced drug   

product means a drug that incorporates  
or utilizes a genetically targeted      
technology 7as defined in section       
#ebi;,a7c77#b7 of the ,federal ,food1   
,drug1 and ,cosmetic ,act7 that may     
result in the modulation 7including     
suppression1 up-regulation1 or          
activation7 of the function of a gene or
 its associated gene product4  4